Executive Personnel
 
Our Research and Development Department at Medical Diagnostic Laboratories (MDL) is comprised of experts in the fields of Molecular Biology, Molecular Virology, Microbiology, Immunology, and Molecular Oncology. Our main theme of research is in the field of infectious diseases with an emphasis on the use of PCR methodologies.
 
Chief Executive Officer & Founder - Eli Mordechai, Ph.D.
 
  • Ph.D. Graduate of Temple University Department of Biochemistry in Philadelphia, Pennsylvania.
  • The Florence Gloria Freedman Cancer Research Award Recipient.
  • Postdoctoral work at The Barrow Neurological Institute specializing in Molecular Neurobiology.
  • Published many research papers in the fields of Infectious Diseases and Chronic Illnesses.
  • Director and Associate Member of the American Association of Bioanalysts.
  • Member of the American Association for the Advancement of Science and the American Society of Microbiology.
  • Licensed and certified Laboratory Director for the New York State Department of Health.
  • Serves on the Board of Trustees of Rider University.
  • Appointed to the Science Advisory Boards of the Hepatitis B Foundation, Burlington County College and Rider University.
  • 2007 Ernst and Young Entrepreneur of the Year Award Recipient.
  • Recipient of the Distinguished Achievement Entrepreneur Award of Hamilton Township.
 
Martin E. Adelson, Ph.D. – Vice President and Director of Research & Development
 
  • Ph.D. Graduate of the Fels Institute for Cancer Research and Molecular Biology at Temple University in Philadelphia, PA.
  • Recipient of The Daniel Swern Memorial Fellowship.
  • Postdoctoral work on HIV-1 based gene therapy at the University of Medicine and Dentistry of New Jersey.
  • Recipient of a competitive Postdoctoral Fellowship from the National Lung and Blood Institute of the National Institute of Health entitled “Pseudotyped Lentiviral Vector Gene Therapy of Hemophilia”.
  • Currently investigating co-infection aspects of Lyme Disease, participating in clinical pathogen prevalency studies with physicians and researchers in the New Jersey, Pennsylvania, and California areas, and developing new clinical diagnostic assays.
  • Member of the American Society of Microbiology and the International Organization for Mycoplasmology, and the Association for Molecular Pathology.
  • Guest reviewer for Infection and Immunity (2003), Clinical and Diagnostic Laboratory Immunology (2003), Applied and Environmental Microbiology (2003-2004), Clinical and Diagnostic Laboratory Immunology (2003-2004), Clinical and Diagnostic Microbiology (2003, 2005), Journal of Clinical Microbiology (2003-2007), Journal of Applied and Experimental Microbiology (2003-2004), and the Journal of Dermatological Science (2005), and Clinical Vaccine Immunology (2007).
  • Appointed to the Editorial Board of the Journal of Clinical Microbiology (2005 -2008).
  • Member of the Thomas Jefferson University Biotechnology Advisory Committee.
 
Richard C. Tilton, Ph.D. - Medical Co-Director
 
  • 30 years experience in Clinical Microbiology and Immunology.
  • 200 peer reviewed papers and 15 books.
  • Professor of Laboratory Medicine at the University of Connecticut School of Medicine, retired.
  • Medical Staff: John Dempsey Hospital, University of Connecticut Health Center, retired; Hamilton, Bermuda, Department of Pathology (1994-2000).
  • Founder and Medical Director, BBI Clinical Laboratories, a national reference laboratory for Infectious Diseases.
  • Founder and Principal - The Tilton Technical Group, a consulting consortium for clinical and environmental microbiology, laboratory compliance and regulation, and laboratory information systems.
  • Board Certified, Public Health and Medical Microbiology: American Board of Medical Microbiology.
  • Editor-In-Chief, Journal of Clinical Microbiology, 1990-2000.
 
Intellectual Property
United States Patent Portfolio
 
  1. Adelson, M.E., Trama, J., and Mordechai, E.M. Methods and compositions for detecting and identifying species of Candida. Filed 12/29/2005. Patent Number: 11/321,984.

  2. Adelson, M.E., Feola, M., Trama, J.P., and Mordechai, E. Methods and Composition Related Thereto for Detecting and Identifying Distinct Species of Nucleic Acids from Causative Agents. Filed 10/7/2005. US Patent Assignment Number: 11/246,976.

  3. Adelson, M.E., Mordechai, E. A Method and Kit for the Collection and Maintenance of the Detectability of a Plurality of Microbiological Species in a Single Gynecological Sample. Filed 01/31/2006.

  4. Adelson, M.E., Mordechai, E. A Method of Receiving and Handling a Plurality of Clinical Samples for Reporting a Sum of Diagnostic Results for Each Sample. Filed 01/31/2006.

  5. Feola, M., Gofman, L., Mordechai, E., Adelson, M.E., Compositions and Methods for Detecting Human Metapneumovirus. Filed 3/22/2007.
 
 

Toll Free:
Office:
Fax:

877.269.0090
609.570.1000
609.570.1050

  

E-mail:
 Contact Us
& Directions:

info@mdlab.com

Click Here
 
Medical Diagnostic Laboratories, L.L.C.
2439 Kuser Road
•
 Hamilton, NJ 08690
•
 Copyright © 1997-2006